ArticleAnnals of surgical treatment and research2026
Distinct prognostic impact of circumferential resection margin and adverse histologic features after intersphincteric resection for ultra-low rectal cancer following chemoradiotherapy: a retrospective cohort study.
Article in Annals of surgical treatment and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Circumferential resection margin (CRM) involvement after intersphincteric resection (ISR) is uncommon but clinically important. We evaluated the association of CRM status and adverse histopathologic features with recurrence after ISR following neoadjuvant concurrent chemoradiotherapy (CCRT). Methods: From 2011 to 2022, 520 patients underwent ISR for ultra-low rectal cancer (≤3 cm from the anal verge) at a single tertiary center. Among them, 326 who received CCRT were analyzed. Clinicopathologic variables were evaluated in relation to disease-free survival (DFS), local recurrence-free survival (LRFS), and distant recurrence-free survival (DRFS). Multivariable Cox regression evaluated adjusted associations. Results: CRM involvement occurred in 8 patients (2.5%). Fifty-four patients (16.6%) developed recurrence: 17 local only, 34 distant only, and 3 both. Five-year DFS, LRFS, DRFS, and overall survival were 74.8%, 87.5%, 85.5%, and 91.4%, respectively. CRM involvement was associated with inferior DFS (45.0% Conclusion: CRM involvement was associated predominantly with poorer local control after ISR following CCRT, whereas adverse microscopic features, particularly perineural invasion, showed broader associations with both local and distant recurrence. The combined assessment of CRM status and microscopic tumor invasiveness may therefore provide complementary prognostic information after ISR for ultra-low rectal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.